-
FDA Notifies Pharmaceutical Companies that Studies Conducted by Cetero Research May Require ReevaluationThe FDA is notifying pharmaceutical companies that bioanalytical studies conducted by Cetero Research, Houston, Texas (Cetero) between April 2005 and June 2010 in support of marketing applications may2011/7/27
-
VeganZyme supplement may aid in reducing digestive discomfort and symptomsEvery year the American public spends billions of dollars on food and beverages that are toxic to the body and devoid of natural enzymes. These may include processed, microwaved or cooked food, meat,2011/7/27
-
SFDA issues Opinions on Improving Cosmetic Evaluation and Approval MechanismIn order to strengthen the management of cosmetic evaluation and approval, improve the evaluation and approval mechanism, standardize the evaluation and approval conducts and define the evaluation and2011/7/26
-
GlaxoSmithKline Flu Jab Linked to Sleep DisorderGlaxoSmithKline swine flu vaccine Pandemrix has been linked to narcolepsy in young people and should be used as a last line of protection, the European Medicines Agency has said. The agency recomme2011/7/26
-
Merck and Simcere Sign Agreement to Establish PioneeringPartnership Focused on Providing Significantly Enhanced Access to Quality Medicines for Chinese Patients WHITEHOUSE STATION, N.J., and NANJING, China, July 21, 2011 – Merck & Co., Inc., Whiteh2011/7/25
-
SFDA issues technical guidelines for clinical research of TCM and natural medicine treating angina pectoris and female climacteric syndromeIn order to scientifically standardize and guide the clinical research of traditional Chinese medicine (TCM) and natural medicines and ensure research quality, the State Food and Drug Administration (2011/7/22
-
Roche, Merck sign new non-exclusive agreement for HCV triple combination therapyMerck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that it has signed a new non-exclusive agreement with Roche (SIX: RO, ROG; OTCQX: RHHBY), through the companies' r2011/7/22
-
Purdue Pharma develops new online resource for combating prescription drug abuseA new online resource, RxSafetyMatters.org, is now available to help healthcare professionals, law enforcement, and community organizations combat the illegal diversion and abuse of prescription medic2011/7/21
-
New transgenic mouse could predict toxicity of targeted cancer drugsOnly one in twenty cancer drugs makes its way from the laboratory to become an approved pharmaceutical product. The majority of new agents are only shown to be unsuitable in the later phases of clinic2011/7/21
-
Patients who use anti-depressants more likely to suffer relapsesPatients who use anti-depressants are much more likely to suffer relapses of major depression than those who use no medication at all, concludes a McMaster researcher. In a paper that is likely to2011/7/20